| |
| |
|
| Insider
Information: |
Podlesak Dennis |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
563,411 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,354,926 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
563,411 |
|
|
| Total
Value |
$3,354,926 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 34.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Avanir Pharmaceuticals |
AVNR |
Director |
2014-02-12 |
336,394 |
2006-02-13 |
0 |
Premium* |
|
|
Alliqua BioMedical Inc |
ALQA |
Director |
2019-05-03 |
85,254 |
2019-05-03 |
0 |
Premium* |
|
|
Syndax Pharmaceuticals Inc |
SNDX |
|
2024-02-07 |
141,763 |
2021-02-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2024-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
34,000 |
141,763 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
32,000 |
107,763 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2022-09-16 |
4 |
AS |
$23.43 |
$280,607 |
D/D |
(11,975) |
75,763 |
0 |
% |
|
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2022-09-16 |
4 |
OE |
$6.32 |
$75,879 |
D/D |
11,975 |
82,319 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2022-09-15 |
4 |
AS |
$24.20 |
$1,617,381 |
D/D |
(66,840) |
75,763 |
0 |
% |
|
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2022-09-15 |
4 |
OE |
$6.32 |
$422,429 |
D/D |
66,840 |
142,603 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2022-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
32,000 |
75,763 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2021-10-05 |
4 |
A |
$0.00 |
$0 |
D/D |
463 |
43,763 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2021-04-22 |
4 |
B |
$14.11 |
$197,077 |
D/D |
13,967 |
43,300 |
0.01 |
% |
|
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2021-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
29,333 |
29,333 |
0 |
- |
|
| ALQA |
Alliqua BioMedical Inc |
Director |
– • – |
2019-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
85,254 |
85,254 |
0 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
Director |
– • – |
2014-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
28,900 |
336,394 |
0 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
Director |
– • – |
2011-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
238,594 |
0 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
Director |
– • – |
2009-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
168,594 |
0 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
Director |
– • – |
2008-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
56,911 |
108,594 |
0 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
officerTitle |
– • – |
2007-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
44,248 |
51,683 |
0 |
- |
|
| AVNR |
Avanir Pharmaceuticals |
Director |
– • – |
2006-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
6,435 |
6,435 |
|
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
